TABLE 1.
Baseline Characteristics
| Characteristic | Data |
|---|---|
| Age (y) | 57 (44–66) |
| Localization* (main complaint) | |
| Temporal (epilepsy) | 2 |
| Falx (nausea) | 1 |
| Optic meningioma (proptosis-induced pain) | 1 |
| Previous treatments | |
| Surgical resection | 4 |
| External-beam radiation therapy | 4 |
| Temozolomide | 1 |
| Unifocal/multifocal | 2/2 |
| Histopathology WHO grade | |
| 1 | 0 |
| 2 | 3 |
| 3 | 1 |
| Median number of treatment cycles | 4 (3–4) |
| Intravenous | 2 (1–2) |
| Intraarterial | 2 (1–3) |
| Median activity per cycle (MBq) | 7,338 (3,668†–7,637) |
| Median interval per cycle (wk) | 6.3 (5.7–10) |
*Largest or most symptomatic lesion only.
†Final cycle of 1 patient was delayed out of precaution because of grade 3 leukopenia, with activity reduction of 50%.
Qualitative data are number; continuous data are median and range.